Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

AbbVie’s 2018: Revenues Up, Earnings Down

AbbVie reported a loss of $1.83 billion for the fourth quarter of 2018. Overall revenues were up for full-year 2018, however, hitting $32.75 billion compared to $28.2 billion in 2017.

Read More »

Indivior temporarily stops rival Alvogen’s generic launch

Indivior said a U.S. district court had granted the British drugmaker a temporary restraining order, stopping rival Alvogen from launching cut-price versions of the company’s blockbuster opioid addiction treatment.

Read More »

UnitedHealth Sues Former Exec for Taking Secrets to Amazon-Berkshire-Chase Joint Venture

UnitedHealth Group’s Optum unit is suing David Smith, a former information technology executive, for breach of contract.

Read More »

Health insurers team up with IBM on blockchain project

A group of health insurers, including CVS Health Corp.’s Aetna, have teamed up with IBM Corp. to create a blockchain network aimed at cutting costs in the healthcare industry.

Read More »

Bristol-Myers Squibb 2018 Full-Year Financials: “Superior Commercial Performance”

Bristol-Myers Squibb reported that fourth-quarter 2018 revenue was up 10 percent and full-year revenue increased 9 percent.

Read More »

CVS unveils ‘Beauty Marks’ in stores, warning shoppers of edited images

CVS Pharmacy unveiled an initiative in U.S. stores, labeling photos of models in the drugstore chain’s beauty aisles to make it clear whether the images had been digitally altered.

Read More »

Bristol-Myers pulls U.S. application for combo lung cancer treatment

Bristol-Myers Squibb withdrew the U.S. approval application for a combo of the cancer immunotherapy drugs Opdivo and Yervoy.

Read More »

Argentum Medical Awarded $8.4M BARDA Contract for Silverlon Wound Technology to Prepare U.S. for Nuclear and Radiation Emergencies

To prepare for radiological and nuclear emergencies, the U.S. Department of Health and Human Services (HSS) announced it will work with Argentum Medical LLC to repurpose the company’s commercial Silverlon technology for radiation injuries of the skin.

Read More »

Vertex Pharma boots out COO for ‘personal behavior’ violations

Vertex Pharmaceuticals Inc. terminated the employment of the company’s chief operating officer and interim chief financial officer, Ian Smith, citing “personal behavior” that violated its code of conduct.

Read More »

The Benefits and Challenges of Bringing Tech to the Pharma Industry

Pharma companies are always trying to innovate in any way they can. Any advancement that may help with this quickly becomes a big focus. One such area that pharma companies are now focusing on is bringing more tech into the industry.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

February 2019 Focus: Agenda 2019, Top 10 Pipelines To Watch, Value Of Pharmaceuticals, and more!


Ad Right Bottom